List

Reset

The Award database is continually updated throughout the year. As a result, data for the given year is not complete until April of the following year. Annual Reports data is a snapshot of agency reported information for that year and hence might look different from the live data in the Awards Information charts.

  1. STTR Phase I: Hydrogen Storage in Catalytically-modified Porous Silicon

    SBC: Green Fortress Engineering, Inc            Topic: CT

    This STTR Phase I project will study the storage of hydrogen on a novel material produced from silicon - the same substance used to make solar panels and computer chips. This unique and patented approach has the potential to eclipse all prior methods of hydrogen storage in terms of pressure, temperature, safety, cost, and convenience. Silicon is earth-abundant and benign to humans - it is even pro ...

    STTR Phase I 2017 National Science Foundation
  2. SBIR Phase I: Locating a breast tumor with sub-millimeter accuracy to improve the precision of surgery

    SBC: Vibronix, Inc.            Topic: BM

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to provide a tool for real-time direct visual guidance of surgery with sub-millimeter accuracy in a clinical relevant setting. It is a critical challenge to locate an implanted device, interventional device, needle biopsy device, or lesion that is planned to be removed during a surgical pro ...

    SBIR Phase I 2017 National Science Foundation
  3. SBIR Phase I: Validation and optimization of balance and gait assessment technology in order to identify fall-risk in older adults

    SBC: SmartGait LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the ability to quickly and easily identify fall-risk in an aging population. Falls are the leading cause of fatal and non-fatal injuries in older adults, resulting in loss of independence and financial burden (predicted to exceed $54 and $101 billion in 2020 and 2030). There is a critical n ...

    SBIR Phase I 2017 National Science Foundation
  4. SBIR Phase I: Passive Radiative Composite Material

    SBC: PC Krause and Associates, Inc.            Topic: MI

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project will be observed through a direct reduction in the energy consumption required by large industrial facilities, commercial buildings, campuses, and homes. Due to reduced cooling demands as a result of carefully designed radiative properties, the sustainability of federal and industry facilities ...

    SBIR Phase I 2017 National Science Foundation
  5. SBIR Phase II: Semantic Link Association Prediction for Phenotypic Drug Discovery

    SBC: Data2Discovery Inc            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of an informatics-based software platform that will help pharmaceutical companies create more new, effective, and safe drugs earlier in the R&D pipeline. This software platform will address a need for data integration and analysis tools to aid pharmaceutical researchers in ...

    SBIR Phase II 2017 National Science Foundation
  6. SBIR Phase II: Enabling Techologies for Energy-Centric Mobile App Design to Extend Mobile Device Battery Life

    SBC: Mobile Enerlytics LLC            Topic: IC

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will result from it having far-reaching societal, commercial, and technological impact. (1) Initial research by the Principal Investigator on analyzing the energy drain of AngryBirds has demonstrated the severe energy inefficiency of popular mobile apps in today's app market. The importance o ...

    SBIR Phase II 2017 National Science Foundation
  7. Tools to Measure Non-Receptor Tyrosine Kinase Activities for Drug Discovery and Biomarker Analysis

    SBC: KINASENSE, LLC            Topic: 102

    Project Abstract Advanced cell based technologies for kinase activity profiling are needed for earlier identification of next generation kinase inhibitors and to enable clinical evaluation of kinase activity biomarkers The long term goal of this proposal is to generate targeted kinase activity tests compatible with viable cells from patient derived samples The objectives in this proposal work t ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Next generation quantitative HCV drug resistance assay

    SBC: MEDOSOME BIOTEC, LLC            Topic: 300

    Project Summary Abstract The objective of this Phase I STTR application is to develop a next generation quantitative drug resistance assay that can accurately determine the abundance and linkage of HCV variants resistant to direct antiviral agents DAAs Drug resistance to HCV is a major threat to achieving sustained virologic response SVR in HCV infected individuals RAVs pre exist in patients ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Development of CaSR nutrient therapy for childhood diarrhea

    SBC: MEDOSOME BIOTEC, LLC            Topic: NICHD

    Project Abstract Acute infectious diarrhea is a worldwide problem especially among infants young children and immune compromised patients Sadly million children die each year not because of the infections causing diarrhea but due to the associated dehydration The pro absorptive Oral Rehydration Solution ORS is the only recommended oral therapy for children with acute diarrhea yet it ...

    STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Personalized dosing of dichloroacetate for the treatment of rare and common diseases

    SBC: MEDOSOME BIOTEC, LLC            Topic: NICHD

    Pyruvate dehydrogenase complex PDC deficiency PDCD is a rare disease of mitochondrial energy failure in which the life of expectancy of affected children is severely truncated Treatment of PDCD remains a serious unmet challenge There has never been a controlled trial of any intervention for PDCD thus there is no proven therapy for affected patients Dichloroacetate DCA represents the f ...

    STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government